ABSTRACTS
- Home>
- 2008 Stone Conference>
- Abstracts
ABSTRACT SUBMISSION DEADLINE: February 15, 2008
CALL FOR ABSTRACTS
The submission of an abstract constitutes the author’s commitment to present the abstract as accepted. Abstracts must be written in English and, if accepted, presented in English. All accepted abstracts will be presented in an unmoderated poster session.
Size: The size of the abstract is limited to 400 words. This includes title, body of abstract, tables, and graphics.
Title: The title should clearly define the topic and contain no abbreviations.
Authors: List the primary author’s full name, followed by the other authors’ names. Spell out completely the names of all authors using full first name, middle initial, and last name. The presenting author’s name should be underlined.
Body of Abstract: The abstract should be informative and detailed. The body must contain four separate paragraphs: 1) Introduction and Objectives; 2) Methods; 3) Results; and 4) Conclusions. It is NOT acceptable to state that “The results will be discussed.” Inclusion of specific data is helpful to the reviewers. Standard abbreviations may be used as follows: on first use, spell out the full term and follow with the abbreviation in parentheses. Proprietary names of drugs are not allowed; generic names must be used.
Source of Funding: Grant support must be indicated.
Conflict of Interest and Disclosure Statement: All authors must disclose conflicts of interest.
Key Words: Authors must select up to three key word entries that describe the subject of the abstract.
